Skip to main content

Day: October 8, 2025

Wakefield Council Selects Blink Charging UK to Support Development and Expansion of Public EV Charging Infrastructure

Blink will install, own, and operate 184 EV chargers across the Wakefield district as part of a regional net-zero drive  London, UK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, has announced its wholly owned subsidiary, Blink Charging UK Ltd., has been selected by Wakefield Council to install, own, and operate 54 on-street and 130 off-street EV chargers throughout the district, with a focus on areas where access to charging has been limited. Backed by a £282,000 investment through the UK government’s Local Electric Vehicle Infrastructure (LEVI) funding secured by the West Yorkshire Combined Authority (WYCA), the collaboration will accelerate the realization of Wakefield’s commitment...

Continue reading

GlobalFoundries Announces Conference Call to Review Third Quarter 2025 Financial Results

MALTA, N.Y., Oct. 08, 2025 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Wednesday, November 12, 2025, at 8:30 a.m. ET following the release of the company’s third quarter 2025 financial results. Conference Call and Webcast Information The company will host a conference call with the financial community on Wednesday, November 12, 2025, at 8:30 a.m. ET. Interested parties may join the scheduled conference call by registering here. The company’s financial results and a webcast of the conference call will be available on GlobalFoundries’ Investor Relations website at https://investors.gf.com. About GF GlobalFoundries (GF) is a leading manufacturer of essential semiconductors the world relies on to live, work and connect. We innovate and partner with customers to deliver more...

Continue reading

Verisk to Announce Fiscal Third-Quarter 2025 Results on October 29, 2025

JERSEY CITY, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, will report its financial results for the fiscal third quarter ended September 30, 2025, on Wednesday, October 29, 2025, before the market open. The press release, with accompanying financial information, will be posted on the Verisk investor website at http://investor.verisk.com. Verisk’s management team will host a live audio webcast to discuss the financial results and business highlights on Wednesday, October 29 at 8:30 a.m. ET. All interested parties are invited to listen to the live event via webcast on the Verisk investor website at http://investor.verisk.com. The discussion will also be available through dial-in number 1-800-715-9871 for U.S./Canada participants...

Continue reading

NewtekOne, Inc. to Report Third Quarter 2025 Results and Host a Conference Call on Wednesday, October 29, 2025

BOCA RATON, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) will report its third quarter 2025 financial results after the market closes on Wednesday, October 29, 2025. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive Officer and Frank DeMaria, Chief Financial Officer of NewtekOne at 4:30 pm ET on Wednesday, October 29, 2025. Please note, to receive a dial-in number for the conference call or to listen to the webcast, interested participants are encouraged to pre-register online at NewtekOne Third Quarter 2025 Financial Results beginning today and up until 15 minutes prior to the start of the October 29, 2025 conference call in order to reserve a listening position on the call. Concurrent with the release of 3Q25 financial results, a corresponding earnings...

Continue reading

BTCS to Participate in Water Tower Fireside Chat on Thursday, October 9, 2025

WAYNE, Pa., Oct. 08, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that Charles Allen, Chairman and CEO, will participate in the upcoming Water Tower Research Fireside Chat Series taking place Thursday, October 9, 2025, at 1:00 p.m. Eastern Time. The Fireside Chat will be hosted by Dr. John Roy, Managing Director – Technology at Water Tower Research, and will cover the following topics:The latest news in Ethereum Trends within Digital Asset Treasuries (“DATs”) Updates from BTCS How BTCS is differentiating from the competitionThis event is open access for all investors to participate. Interested parties can register for the event through Water Tower Research at: https://us06web.zoom.us/webinar/register/1817591680658/WN_CsPeqQ4DSDO9FfdH2FEQGg About...

Continue reading

Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting

Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post PRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce its exhibition at the CNS Annual Meeting, from October 11 through 15, 2025, in Los Angeles, California. The company’s booth will spotlight its industry-leading products, while featuring two recent additions to the portfolio – Durepair Dura Regeneration Matrix and Mayfield Ghost Base Unit, Post. Durepair Dura Regeneration Matrix is a strong suturable graft1 that complements Integra’s extensive portfolio of dural grafts and sealants, and the Mayfield Ghost device is engineered with minimal artifact materials to support clear visualization of anatomical structure for...

Continue reading

Brag House CEO Lavell Juan Malloy Highlights Fintech-Inspired Strategy for Gen Z Engagement on Fintech TV

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, today highlighted a recent interview with CEO, Lavell Juan Malloy, on Fintech TV, which was filmed live from the New York Stock Exchange. The full interview is available HERE In the interview, Malloy detailed the Company’s unique media-tech model, which incorporates a fintech-like layer to drive user stickiness and create a powerful data engine. A central theme was the platform’s strategy to transform passive spectators into active participants through its proprietary in-app non-monetary currency and prediction features. Key points from the interview include:Digital Currency and...

Continue reading

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growthExtensive track record in commercializing advanced laboratory testing and insurer strategiesIRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Directors as an independent board member. Mr. Huff brings decades of leadership experience in the diagnostics and healthcare services industry, including serving as Chief Executive Officer of LabCorp Diagnostics, one of the world’s largest clinical laboratories. Mr. Huff is a hands-on, inspirational, and growth-oriented executive who possesses a proven track record of successfully managing commercial laboratories of varying sizes, including...

Continue reading

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

MORRISVILLE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its third FDA inspection, further affirming the quality and compliance of its Direct-to-Patient Site for clinical research. The inspection concluded with a No Action Indicated (NAI) categorization recommendation by the inspector, with no objectionable conditions noted and no Form 483 issued. The review centered on Science 37’s contribution in a registrational Phase 3 primary biliary cholangitis (PBC) study, in which the company played a significant role, enrolling 47% of the US study population. The FDA evaluated internal processes, technology platforms, data integrity, patient safety measures, protocol adherence, Principal Investigator oversight, and all associated...

Continue reading

Change of interest rate adjustment date for Jyske Rentetilpasning F1

To Nasdaq Copenhagen A/S                                            8 October 2025 Announcement 87 /2025 Change of interest rate adjustment date for Jyske Rentetilpasning F1        Jyske Realkredit is changing the interest rate adjustment date for new offers of Jyske Rentetilpasning F1 (Private and Business) from January 1st to October 1st. The change will take effect from October 22nd, 2025. Questions regarding the bond sale as well as technical matters may be addressed to Jyske Realkredit, Lars Hasløv, Head of mortgage ALM tel. (+45) 89 89 92 19 or Christian Bech-Ravn, Head of Investor Relations, tel. (+45) 89 89 92 25. The information will also be available on Jyske Realkredit’s web site at jyskerealkredit.com. Yours sincerely,Jyske Realkredit Please observe that the Danish version of this announcement prevails. www.jyskerealkredi...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.